非酒精性脂肪性肝病患者血清维生素A水平、肝脏脂肪含量与胰岛素抵抗的相关性分析

丁智勇; 卜乐; 鲁鸿燕; 饶正轩

doi:10.3969/j.issn.1001-5256.2017.12.021

非酒精性脂肪性肝病患者血清维生素A水平、肝脏脂肪含量与胰岛素抵抗的相关性分析

DOI: 10.3969/j.issn.1001-5256.2017.12.021

1. 上海市第十人民医院崇明分院内分泌科
2. 上海市第十人民医院内分泌科

基金项目:

崇明县科学技术委员会科技项目(cky2017-21)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 551
- HTML全文浏览量: 53
- PDF下载量: 95
- 被引次数: 12
出版历程
- 收稿日期: 2017-07-07
- 出版日期: 2017-12-20

Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease

Department of Endocrinology, Shanghai Tenth People's Hospital Chongming Branch

Research funding:

摘要

摘要:
目的观察和分析非酒精性脂肪性肝病（NAFLD）患者肝脏脂肪含量（LFC）与血清维生素A（VA）水平及胰岛素抵抗（IR）之间的关系。方法征集2016年2月-2017年1月上海市崇明地区初诊NAFLD患者200例和健康志愿者98例。根据口服75 g葡萄糖耐量试验和胰岛素释放试验,将NAFLD患者分为单纯NAFLD组（n=91）、NAFLD合并糖调节受损（IGR）组（n=69）,NAFLD合并2型糖尿病（T2DM）组（n=40）,另将98例健康志愿者作为健康对照组。用稳态模型评估IR,用高效液相色谱法检测血清VA水平,采用3.0 T质子磁共振波谱进行LFC检测。符合正态分布的计量资料多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验;不符合正态分布的计量资料组间比较采用Kruskal-Wallis H检验,进一步两两比较采用Mann-Whitmey U检验。计数资料组间比较采用Pearsonχ2检验。相关性分析采用Spearman相关性分析法。结果健康对照组、单纯NAFLD组、NAFLD合并IGR组和NAFLD合并T2DM组4组间FPG、葡萄糖耐量试验负荷后2 h血糖（2h PG...
- 非酒精性脂肪性肝病 /
- 维生素A /
- 肝脏脂肪含量 /
- 胰岛素抵抗
Abstract:
Objective To investigate the correlation of liver fat content ( LFC) with serum vitamin A ( VA) level and insulin resistance ( IR) in patients with nonalcoholic fatty liver disease ( NAFLD) . Methods A total of 200 patients with an initial diagnosis of NAFLD in Shanghai Chongming from February 2016 to January 2017 were enrolled. According to the results of oral glucose tolerance test with 75 g glucose and insulin releasing test, NAFLD patients were divided into simple NAFLD group with 91 patients, NAFLD-impaired glucose regulation ( IGR) group with 69 patients, and NAFLD-type 2 diabetes mellitus ( T2 DM) group with 40 patients. A total of 98 healthy volunteers were enrolled as healthy control group. The homeostasis model was used to evaluate IR, high-performance liquid chromatography was used to measure serum VA level, and 3. 0 T1 H-magnetic resonance spectroscopy was used to measure LFC. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the LSD-t-test was used for further comparison between two groups; the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups, and the Mann-Whitmey U test was used for further comparison between two groups. The Pearson's chi-squared test was used for comparison of categorical data between groups. A Spearman correlation analysis was also performed. Results There were significant differences in fasting plasma glucose ( FPG) , 2-hour postprandial glucose ( 2 h PG) , and Hb Alc between the healthy control group, simple NAFLD group, NAFLD-IGR group, and NAFLD-T2 DM group ( F = 303. 8, 133. 1, and 249. 3, all P < 0. 01) . The simple NAFLD group, NAFLD-IGR group, and NAFLD-T2 DM group had significant increases in FPG, 2 h PG, and Hb Alc ( all P < 0. 01) , and compared with the simple NAFLD group, NAFLD-IGR group, and NAFLD-T2 DM group, the healthy control group had significant reductions in body mass index, alanine aminotransferase, triglyceride, and low-density lipoprotein ( all P < 0. 01) . The simple NAFLD group, NAFLD-IGR group, and NAFLD-T2 DM group had significantly higher serum VA level, LFC, and HOMA2-IR than the healthy control group ( F = 9. 2, H = 216. 1, and H = 151. 0, all P < 0. 01) . HOMA2-IR and LFC gradually increased in the simple NAFLD group, NAFLD-IGR group, and NAFLD-T2 DM group ( H = 26. 7 and 38. 6, both P < 0. 01) . There were significant differences in HOMA2-IR and LFC between the NAFLD-IGR group and the NAFLD-T2 DM group ( U = 995 and 800, both P < 0. 01) ; there were also significant differences in HOMA2-IR, LFC, and VA between the NAFLD-IGR group and the simple NAFLD group, as well as between the NAFLD-T2 DM group and the simple NAFLD group ( all P < 0. 05) . LFC was positively correlated with VA ( R2= 0. 103, P < 0. 001) and HOMA2-IR ( R2= 0. 531, P < 0. 001) . Conclusion The increase in LFC is closely associated with high serum VA level and disorder of glucose metabolism in patients with NAFLD.
- nonalcoholic fatty liver disease /
- vitamin A /
- liver fat content /
- insulin resistance

HTML全文

参考文献(20)

[1]FAN JG, ZHU J, LI XJ, et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.

[2]MAILAMUGULI, JIANAERGULI XK, CAI W, et al.Association between non-high-density lipoprotein cholesterol and nonalcoholic fatty liver disease in postmenopausal Uyghur women in Xinjiang, China[J].J Clin Hepatol, 2016, 32 (6) :1155-1159. (in Chinese) 买拉木古丽, 加那尔古丽·夏坎, 蔡雯, 等.非高密度脂蛋白胆固醇水平与新疆维吾尔族绝经后女性非酒精性脂肪性肝病的关系[J].临床肝胆病杂志, 2016, 32 (6) :1155-1159.

[3]TILG H, MOSCHEN AR, RODEN M.NAFLD and diabetes mellitus[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (1) :32-42.

[4]TARGHER G, MARCHESINI G, BYRNE CD.Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease:causal association or epiphenomenon?[J].Diabetes Metab, 2016, 42 (3) :142-156.

[5]ZHAO S, LI R, LI Y, et al.Roles of vitamin A status and retinoids in glucose and fatty acid metabolism[J].Biochem Cell Biol, 2012, 90 (2) :142-152.

[6]European Association for the Study of the Liver (EASL) ;European Association for the Study of Diabetes (EASD) ;European Association for the Study of Obesity (EASO) .EASL-EASD-EASOClinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J].J Hepatol, 2016, 64 (6) :1388-1402.

[7] Chinese Society of Diabetes, Chinese Medical Association.Guidelines for the prevention and treatment of type 2 diabetes in China (version 2013) [J].Chin J Diabetes, 2014, 22 (8) :2-42. (in Chinese) 中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2013年版) [J].中国糖尿病杂志, 2014, 22 (8) :2-42.

[8]SZCZEPANIAK LS, NURENBERG P, LEONARD D, et al.Magnetic resonance spectroscopy to measure hepatic triglyceride content:prevalence of hepatic steatosis in the general population[J].Am J Physiol Endocrinol Metab, 2005, 288 (2) :462-468.

[9]BU L, GAO M, QU S, et al.Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance[J].AAPS J, 2013, 15 (4) :1001-1011.

[10]ADAMS LA, LYMP JF, ST SAUVER J, et al.The natural history of nonalcoholic fatty liver disease:a population-based cohort study[J].Gastroenterology, 2005, 129 (1) :113-121.

[11]SUGANAMI T, TANAKA M, OGAWA Y.Adipose tissue inflammation and ectopic lipid accumulation[J].Endocr J, 2012, 59 (10) :849-857.

[12]LAURENS C, MORO C.Intramyocellular fat storage in metabolic diseases[J].Horm Mol Biol Clin Investig, 2016, 26 (1) :43-52.

[13]LEWIS GF, CARPENTIER A, ADELI K, et al.Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes[J].Endocr Rev, 2002, 23 (2) :201-229.

[14]WANG Z, HU DY.Research advances in quantitative evaluation of liver fat in patients with nonalcoholic fatty liver disease[J].J Clin Hepatol, 2013, 29 (12) :894-896. (in Chinese) 王梓, 胡道予.量化评价非酒精性脂肪性肝病患者肝脏脂肪含量的研究进展[J].临床肝胆病杂志, 2013, 29 (12) :894-896.

[15]KOTRONEN A, JUURINEN L, TIIKKAINEN M, et al.Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes[J].Gastroenterology, 2008, 135 (1) :122-130.

[16]LI R, CHEN W, LI Y, et al.Retinoids synergized with insulin to induce Srebp-1c expression and activated its promoter via the two liver X receptor binding sites that mediate insulin action[J].Biochem Biophys Res Commun, 2011, 406 (2) :268-272.

[17]MILLER VA, RIGAS JR, MUINDI JR, et al.Modulation of alltrans retinoic acid pharmacokinetics by liarozole[J].Cancer Chemother Pharmacol, 1994, 34 (6) :522-526.

[18]OLIVEROS LB, DOMENICONI MA, VEGA VA, et al.Vitamin Adeficiency modifies lipid metabolism in rat liver[J].Br J Nutr, 2007, 97 (2) :263-272.

[19]CHERTOW BS, GOKING NQ, DRISCOLL HK, et al.Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulinsecreting RINm5F cells[J].Pancreas, 1997, 15 (2) :122-131.

[20]KANE MA, FOLIAS AE, PINGITORE A, et al.Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion[J].Proc Nat Acad Sci, 2010, 107 (50) :21884-21889.

施引文献

期刊类型引用(11)

1.	马红梅，王湘琼，聂德. 血清不同类型维生素与妊娠期糖尿病病人胰岛素抵抗、血清细胞因子的相关性. 蚌埠医学院学报. 2024(05): 593-596 . 百度学术
2.	余虹云，孙桂英，丁建芬. 妊娠期高血压疾病患者维生素A、E水平与妊娠结局的关系. 中国医药导报. 2023(05): 82-85 . 百度学术
3.	韩凯婷，刘建宪，王振松，孙启玉，甘洁. T2DM合并非酒精性脂肪性肝病患者脂肪变性程度与胰岛素抵抗的相关性. 中国中西医结合影像学杂志. 2023(03): 319-323 . 百度学术
4.	李呈佳，刘志平，刘影哲，客蕊，池阔，王呈祥. 滋膵饮对2型糖尿病大鼠肝脏糖脂代谢的影响及机制研究. 中药材. 2023(11): 2818-2824 . 百度学术
5.	冯姗姗，索艳，王肃. LncRNA H19在2型糖尿病合并NAFLD患者血清中的表达及与胰岛素抵抗的关系. 广东医学. 2022(04): 520-524 . 百度学术
6.	王雨，王楠，韩璐，曲长君，刘媛媛，付建军. 瞬时弹性成像技术对非酒精性单纯性脂肪肝的诊断价值及受控衰减系数与糖脂代谢的相关性分析. 现代生物医学进展. 2021(05): 958-961+986 . 百度学术
7.	段伯焕，杨青岳，张梦雅，帕力旦·吾布尔. 老年糖尿病患者肝脏脂肪含量与代谢综合征发生的相关性. 疑难病杂志. 2021(06): 565-568 . 百度学术
8.	李帆，李明. 二甲双胍、阿卡波糖及西格列汀治疗2型糖尿病合并非酒精性脂肪性肝病的疗效. 中国肝脏病杂志(电子版). 2020(01): 50-55 . 百度学术
9.	孙宇焱，丁三珍. 血清中铁蛋白、胆红素、Hcy水平与T2DM伴NAFLD患者病情程度的关系. 标记免疫分析与临床. 2020(08): 1317-1319+1353 . 百度学术
10.	周勇锋，于浩，沈景林，周长海，房恒通，金永成，赵云，王新，张晶. 全反式视黄酸对饲喂高脂饲粮大鼠血糖和血脂的影响. 黑龙江畜牧兽医. 2018(09): 205-207 . 百度学术
11.	张绍仁，胡静娴，樊晓明. siRNA抑制饥饿素-O-乙酰基转移酶对肝细胞脂肪变性的影响及作用机制. 临床肝胆病杂志. 2018(05): 1060-1067 . 本站查看